Serum elevation of B lymphocyte stimulator does not increase regulatory B cells in glioblastoma patients undergoing immunotherapy. [electronic resource]
Producer: 20160606Description: 205-11 p. digitalISSN:- 1432-0851
- Antibodies -- blood
- Antineoplastic Agents, Alkylating -- pharmacology
- B-Cell Activating Factor -- blood
- B-Lymphocytes, Regulatory -- immunology
- Cancer Vaccines -- administration & dosage
- Dacarbazine -- analogs & derivatives
- ErbB Receptors -- antagonists & inhibitors
- Glioblastoma -- blood
- Humans
- Immunotherapy -- methods
- Interleukin-10 -- metabolism
- Lymphocyte Activation -- immunology
- Lymphocyte Count
- Temozolomide
- Vaccines, Subunit -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.